Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Sarcoma × durvalumab × Clear all

Phase

Phase 2 3 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 20 Lung Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 9 Small Cell Lung Carcinoma 9 Carcinoma, Hepatocellular 9 Neoplasm Metastasis 8 Breast Neoplasms 8 Colorectal Neoplasms 7 Pancreatic Neoplasms 6 Ovarian Neoplasms 6 Melanoma 6 Advanced Solid Tumors 6 Urinary Bladder Neoplasms 5 Triple Negative Breast Neoplasms 5 Uterine Cervical Neoplasms 4 Cholangiocarcinoma 4 Carcinoma, Renal Cell 4 Biliary Tract Neoplasms 4 Recurrence 3 Prostatic Neoplasms 3 Neoplasms 3 Multiple Myeloma 3 Lymphoma, Large B-Cell, Diffuse 3 Head and Neck Neoplasms 3 Vulvar Neoplasms 2 Vaginal Neoplasms 2 Solid Tumor 2 Primary Myelofibrosis 2 Lymphoma, Follicular 2 Liver Neoplasms 2

Interventions

Doxorubicin 23 Cyclophosphamide 23 Gemcitabine 14 Radiotherapy 11 Filgrastim 11 pazopanib 10 Cisplatin 9 pembrolizumab 8 Docetaxel 8 Radiation 7 Ifosfamide 7 Granulocyte Colony-Stimulating Factor 7 Busulfan 7 fludarabine 6 Trabectedin 6 Peripheral Blood Stem Cell Transplantation 6 Mesna 6 Melphalan 6 Ipilimumab 6 Etoposide 6 Carboplatin 6 Bevacizumab 6 selinexor 5 olaratumab 4 aflibercept 4 Topotecan 4 Thiotepa 4 Temozolomide 4 Nivolumab 4 Methotrexate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03085225 2025-09-04

TRAMUNE

Institut Bergonié

Phase 1 Completed

40 enrolled 23 charts

GynecologicSarcoma

Ovarian Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡